| 2019 | 2018 Korean Liver Cancer Association-National Cancer Center Korea Practice Guidelines for the Management of Hepatocellular Carcinoma | 김휘영 | Review |
| 2020 | A Collision Tumor of the Esophagus: Mixed Squamous Cell Carcinoma and Neuroendocrine Carcinoma | 정성애; 조민선; 심기남; 임지영; 태정현; 송은미; 최아름 | Article |
| 2020 | Cervical Lymph Node Involvement above the Supraclavicular Fossa in Breast Cancer: Comparison with Stage IIIC (KROG 18-02) | 김규보 | Article |
| 2018 | Clinical validation of serum endocan (ESM-1) as a potential biomarker in patients with renal cell carcinoma | 김광현 | Article |
| 2015 | Clinicopathologic factors and molecular markers related to lymph node metastasis in early gastric cancer | 정성애; 심기남 | Article |
| 2020 | Epidemiological and Clinical Characteristics of Hepatitis C Virus Infection in South Korea from 2007 to 2017: A Prospective Multicenter Cohort Study | 남준열 | Article |
| 2022 | Hepatocellular carcinoma patients with high circulating cytotoxic T cells and intra-tumoral immune signature benefit from pembrolizumab: results from a single-arm phase 2 trial | 이수진 | Article |
| 2021 | Molecular biomarker testing for non-small cell lung cancer: Consensus statement of the Korean Cardiopulmonary Pathology Study Group | 박혜성 | Review |
| 2014 | Optimal Tailored Screening Protocol after Living Donor Liver Transplantation for Hepatocellular Carcinoma | 홍근 | Article |
| 2021 | Prognostic Value of Alpha-Fetoprotein in Patients Who Achieve a Complete Response to Transarterial Chemoembolization for Hepatocellular Carcinoma | 유권; 김태헌; 김휘영 | Article |
| 2019 | Prolyl hydroxylase-3 is a novel renal cell carcinoma biomarker | 김광현 | Article |
| 2021 | Risk of hepatocellular carcinoma in untreated patients with chronic hepatitis b: Independent of hbeag status? | 이민종; 전호수 | Article |
| 2015 | RUNX3 Methylation, Loss of RUNX3 Expression and Clinicopathologic Findings according to Helicobacter pylori CagA in Gastric Carcinoma | 정성애; 조민선; 정혜경; 심기남; 김성은 | Article |
